XML 20 R5.htm IDEA: XBRL DOCUMENT v3.22.0.1
Consolidated Statements of Income - USD ($)
shares in Thousands
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Income Statement [Abstract]      
Net sales $ 18,870,510,000 $ 16,537,433,000 $ 17,522,234,000
Cost of goods sold 12,236,374,000 10,882,592,000 11,662,551,000
Gross profit 6,634,136,000 5,654,841,000 5,859,683,000
Operating expenses:      
Selling, administrative and other expenses 5,162,506,000 4,386,739,000 4,577,610,000
Depreciation and amortization 290,971,000 272,842,000 257,263,000
Provision for doubtful accounts 17,739,000 23,577,000 13,876,000
Restructuring costs 0 50,019,000 100,023,000
Goodwill impairment charge 0 506,721,000 0
Total operating expenses 5,471,216,000 5,239,898,000 4,948,772,000
Non-operating (income) expenses:      
Interest expense, net 62,150,000 91,048,000 91,405,000
Other (99,576,000) (55,473,000) (82,534,000)
Special termination costs 0 0 42,757,000
Total non-operating (income) expenses (37,426,000) 35,575,000 51,628,000
Income before income taxes 1,200,346,000 379,368,000 859,283,000
Income taxes 301,556,000 215,973,000 212,808,000
Net income from continuing operations 898,790,000 163,395,000 646,475,000
Net loss from discontinued operations 0 (192,497,000) (25,390,000)
Net income (loss) $ 898,790,000 $ (29,102,000) $ 621,085,000
Basic earnings (loss) per share:      
Continuing operations (in dollars per share) $ 6.27 $ 1.13 $ 4.44
Discontinued operations (in dollars per share) 0 (1.33) (0.18)
Basic earnings (loss) per share (in dollars per share) 6.27 (0.20) 4.26
Diluted earnings (loss) per share:      
Continuing operations (in dollars per share) 6.23 1.13 4.42
Discontinued operations (in dollars per share) 0 (1.33) (0.18)
Diluted earnings (loss) per share (in dollars per share) $ 6.23 $ (0.20) $ 4.24
Weighted average common shares outstanding (in shares) 143,435 144,474 145,736
Dilutive effect of stock options and nonvested restricted stock awards (in shares) 786 641 681
Weighted average common shares outstanding — assuming dilution (in shares) 144,221 145,115 146,417